Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Graefen

Showing results (391-400 of 920) with videos related to

Pageof 92
Sort By:
European Urology Focus|August 26, 2025
Reply to Lingyu Guo and Tian An's Letter to the Editor re: Mykyta Kachanov, Alexander E. Volk, Fabian Falkenbach, et al. Evaluation of Different National Comprehensive Cancer Network Clinical Practice Guidelines in Prostate Cancer for Germline Genetic Testing in Localized and Locally Recurrent Prostate Cancer. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2025.05.021Mykyta Kachanov, Alexander E Volk, Fabian Falkenbach, et al.
European Urology Focus|June 14, 2025
Evaluation of Different National Comprehensive Cancer Network Clinical Practice Guidelines in Prostate Cancer for Germline Genetic Testing in Localized and Locally Recurrent Prostate CancerMykyta Kachanov, Alexander E Volk, Fabian Falkenbach, et al.
European Urology Oncology|September 21, 2024
Risk of Biochemical Recurrence and Metastasis in Prostate Cancer Patients Treated with Radical Prostatectomy After a 10-year Disease-free IntervalBenedikt Hoeh, Felix Preisser, Fabio Zattoni, et al.
Urologic Oncology|January 24, 2025
Association between frailty and specific comorbidities on oncological outcomes in metastatic hormone-sensitive and castration resistant prostate cancerMike Wenzel, Benedikt Hoeh, Carolin Siech, et al.
European Urology|February 7, 2016
A Critical Analysis of the Current Knowledge of Surgical Anatomy of the Prostate Related to Optimisation of Cancer Control and Preservation of Continence and Erection in Candidates for Radical Prostatectomy: An UpdateJochen Walz, Jonathan I Epstein, Roman Ganzer, et al.
World Journal of Urology|July 12, 2018
Inverse stage migration patterns in North American patients undergoing local prostate cancer treatment: a contemporary population-based update in light of the 2012 USPSTF recommendationsSami-Ramzi Leyh-Bannurah, Pierre I Karakiewicz, Raisa S Pompe, et al.
World Journal of Urology|February 13, 2021
Neoadjuvant treatment with androgen receptor signaling inhibitors prior to radical prostatectomy: a systematic reviewGaëtan Devos, Bram Vansevenant, Gert De Meerleer, et al.
Urologic Oncology|February 6, 2017
Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progressionJonas Schiffmann, Georg Salomon, Derya Tilki, et al.
International Journal of Cancer|May 13, 2008
Mortality at 120 days after prostatic biopsy: a population-based study of 22,175 menAndrea Gallina, Nazareno Suardi, Francesco Montorsi, et al.
European Urology|February 3, 2007
Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomyAndrea Gallina, Felix K-H Chun, Alberto Briganti, et al.
Pageof 92

Showing results (391-400 of 920) with videos related to

Sort By:
Pageof 92
European Urology Focus|August 26, 2025
Reply to Lingyu Guo and Tian An's Letter to the Editor re: Mykyta Kachanov, Alexander E. Volk, Fabian Falkenbach, et al. Evaluation of Different National Comprehensive Cancer Network Clinical Practice Guidelines in Prostate Cancer for Germline Genetic Testing in Localized and Locally Recurrent Prostate Cancer. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2025.05.021Mykyta Kachanov, Alexander E Volk, Fabian Falkenbach, et al.
European Urology Focus|June 14, 2025
Evaluation of Different National Comprehensive Cancer Network Clinical Practice Guidelines in Prostate Cancer for Germline Genetic Testing in Localized and Locally Recurrent Prostate CancerMykyta Kachanov, Alexander E Volk, Fabian Falkenbach, et al.
European Urology Oncology|September 21, 2024
Risk of Biochemical Recurrence and Metastasis in Prostate Cancer Patients Treated with Radical Prostatectomy After a 10-year Disease-free IntervalBenedikt Hoeh, Felix Preisser, Fabio Zattoni, et al.
Urologic Oncology|January 24, 2025
Association between frailty and specific comorbidities on oncological outcomes in metastatic hormone-sensitive and castration resistant prostate cancerMike Wenzel, Benedikt Hoeh, Carolin Siech, et al.
European Urology|February 7, 2016
A Critical Analysis of the Current Knowledge of Surgical Anatomy of the Prostate Related to Optimisation of Cancer Control and Preservation of Continence and Erection in Candidates for Radical Prostatectomy: An UpdateJochen Walz, Jonathan I Epstein, Roman Ganzer, et al.
World Journal of Urology|July 12, 2018
Inverse stage migration patterns in North American patients undergoing local prostate cancer treatment: a contemporary population-based update in light of the 2012 USPSTF recommendationsSami-Ramzi Leyh-Bannurah, Pierre I Karakiewicz, Raisa S Pompe, et al.
World Journal of Urology|February 13, 2021
Neoadjuvant treatment with androgen receptor signaling inhibitors prior to radical prostatectomy: a systematic reviewGaëtan Devos, Bram Vansevenant, Gert De Meerleer, et al.
Urologic Oncology|February 6, 2017
Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progressionJonas Schiffmann, Georg Salomon, Derya Tilki, et al.
International Journal of Cancer|May 13, 2008
Mortality at 120 days after prostatic biopsy: a population-based study of 22,175 menAndrea Gallina, Nazareno Suardi, Francesco Montorsi, et al.
European Urology|February 3, 2007
Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomyAndrea Gallina, Felix K-H Chun, Alberto Briganti, et al.
Pageof 92